Advertisement
Screener

AETHLON MEDICAL, INC. (AEMD) EBITDA

AETHLON MEDICAL, INC. (AEMD) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$1.51M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA -$1.85M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$1.98M*; Operating income -$2.06M; Depreciation and amortization $81.60K*.
  • 2025-09-30: Basis Reported; EBITDA -$1.43M*; Operating income -$1.51M; Depreciation and amortization $79.87K*.

Complete source-backed ebitda history.

Available history
2011-03-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$1.51M(m)(m)(m)(m)$9.15K-$1.90M(m)$549.00K(m)(m)
2026-03-31Reported-$1.85M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-12-31Reported-$1.98M*-$2.06M$81.60K*(m)(m)(m)-$1.87M*(m)$532.78K(m)(m)
2025-09-30Reported-$1.43M*-$1.51M$79.87K*(m)(m)(m)-$1.66M*(m)$294.32K(m)(m)
2025-06-30Reported-$1.71M(m)(m)(m)(m)$0.00-$1.71M(m)$524.00K(m)(m)
2025-03-31Reported-$1.92M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-12-31Reported-$1.73M*-$1.81M$83.81K*(m)(m)$2.19K*-$2.01M*(m)$240.20K(m)(m)
2024-09-30Reported-$2.82M*-$2.90M$85.83K*(m)(m)$0.00*-$2.21M*(m)$261.49K(m)(m)
2024-06-30Reported-$2.53M(m)(m)(m)(m)$0.00-$1.75M(m)$414.66K(m)(m)
2024-03-31Reported-$2.4M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-12-31Reported-$3.48M*-$3.57M$91.47K*(m)(m)$8.81K*-$2.38M*(m)$593.40K(m)(m)
2023-09-30Reported-$3.08M*-$3.18M$91.43K*(m)(m)$6.77K*-$2.70M*(m)$628.45K(m)(m)
2023-06-30Reported-$3.32M(m)(m)(m)(m)$230.38K-$2.48M(m)$678.92K(m)(m)
2023-03-31Reported-$2.4M(m)(m)(m)-417.66%(m)(m)(m)(m)(m)(m)
2022-12-31Reported-$2.77M*-$2.85M$78.13K*$0.00(m)$151.49K*-$1.95M*(m)$558.22K(m)(m)
2022-09-30Reported-$3.61M*-$3.67M$52.57K*$0.00(m)$739.16K*-$2.88M*(m)$852.46K(m)(m)
2022-06-30Reported-$2.88M(m)(m)(m)(m)$41.17K-$2.73M(m)$858.35K(m)(m)
2022-03-31Reported-$3.76M(m)(m)(m)-28670.14%(m)(m)(m)(m)(m)(m)
2021-12-31Reported-$2.51M*-$2.53M$17.67K*$17.12K-14665.38%*$57.93K*-$2.72M*(m)$354.57K(m)(m)
2021-09-30Reported-$1.94M*-$2.01M$69.02K*$131.97K-1469.91%*$40.49K*-$1.88M*(m)$478.20K(m)(m)
2021-06-30Reported-$2.09M(m)(m)(m)-1581.30%$38.37K-$2.07M(m)$587.69K(m)(m)
2021-03-31Reported-$2.25M(m)(m)(m)-6582.57%(m)(m)(m)(m)(m)(m)
2020-12-31Reported-$2.43M*-$2.44M$10.73K*(m)(m)$31.49K*-$2.20M*(m)$461.18K(m)(m)
2020-09-30Reported-$1.76M*-$1.77M$9.27K*(m)(m)$5.33K*-$1.23M*(m)$508.90K(m)(m)
2020-06-30Reported-$1.4M(m)(m)(m)(m)$17.81K-$1.10M(m)$377.17K(m)(m)
2020-03-31Reported-$1.77M(m)(m)(m)-858.52%(m)(m)(m)(m)(m)(m)
2019-12-31Reported-$866.16K*-$876.41K$10.24K*(m)(m)$28.08K*-$1.26M*(m)$218.57K(m)(m)
2019-09-30Reported-$1.70M*-$1.70M$2.88K*(m)(m)$119.09K*-$1.07M*(m)$222.86K(m)(m)
2019-06-30Reported-$1.56M(m)(m)(m)-5211.07%$886.00-$1.25M(m)$248.87K(m)(m)
2019-03-31Reported-$1.58M(m)(m)(m)-1981.22%(m)(m)(m)(m)(m)(m)
2018-12-31Reported-$1.96M*-$1.96M$8.72K*(m)(m)$0.00*-$1.09M*(m)$243.84K(m)(m)
2018-09-30Reported-$1.34M*-$1.35M$7.93K*(m)(m)$0.00*-$991.26K*(m)$178.80K(m)(m)
2018-06-30Reported-$1.09M(m)(m)(m)-727.93%$0.00-$818.43K(m)$194.78K(m)(m)
2018-03-31Reported-$1.26M(m)(m)(m)-1687.98%(m)(m)(m)(m)(m)(m)
2017-12-31Reported-$1.15M*-$1.16M$8.75K*(m)(m)$0.00*-$789.67K*(m)$129.21K(m)(m)
2017-09-30Reported-$1.23M*-$1.24M$9.32K*(m)(m)$0.00*-$1.03M*(m)$168.57K(m)(m)
2017-06-30Reported-$1.15M(m)(m)(m)(m)$23.70K-$1.07M(m)$157.46K(m)(m)
2017-03-31Reported-$1.5M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-12-31Reported-$1.23M*-$1.24M$5.75K*(m)(m)$0.00*-$788.24K*(m)$178.44K(m)(m)
2016-09-30Reported-$2.22M*-$2.23M$10.39K*(m)(m)$1.42K*(m)(m)$333.43K(m)(m)
2016-06-30Reported-$1.12M(m)(m)(m)-24194.91%$1.54K(m)(m)$117.66K(m)(m)
2016-03-31Reported-$1.08M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-12-31Reported-$1.07M*-$1.08M$9.91K*(m)(m)$9.31K*(m)(m)$147.80K(m)(m)
2015-09-30Reported(m)-$1.12M(m)(m)(m)$0.00*(m)(m)$207.68K(m)(m)
2015-06-30Reported(m)-$1.09M(m)(m)(m)$0.00-$798.01K(m)$182.00K(m)(m)
2015-03-31Reported-$1.12M(m)(m)(m)-565.59%(m)(m)(m)(m)(m)(m)
2014-12-31Reported-$1.08M*-$1.09M$9.34K*(m)(m)(m)(m)(m)$214.16K(m)(m)
2014-09-30Reported-$591.85K*-$601.19K$9.34K*(m)(m)(m)(m)(m)$250.39K(m)(m)
2014-06-30Reported-$1.16M(m)(m)(m)-2266.59%(m)-$763.75K(m)$347.00K(m)(m)
2014-03-31Reported-$803,066.00(m)(m)(m)-113.59%(m)(m)(m)(m)(m)(m)
2013-12-31Reported-$1.22M*-$1.23M$9.43K*(m)(m)$61.49K*-$839.35K*(m)$542.38K(m)(m)
2013-09-30Reported-$227.50K*-$229.80K$2.29K*(m)(m)(m)-$522.90K*(m)$293.58K(m)(m)
2013-06-30Reported-$781,362.00(m)(m)(m)-399.48%(m)-$221.62K(m)$338.00K(m)(m)
2013-03-31Reported-$844,425.00(m)(m)(m)-208.83%(m)(m)(m)(m)(m)(m)
2012-12-31Reported-$934.33K*-$936.84K$2.51K*(m)(m)$0.00*-$661.78K*(m)$371.25K(m)(m)
2012-09-30Reported-$797.08K*-$799.79K$2.72K*(m)(m)(m)-$595.31K*(m)$360.09K(m)(m)
2012-06-30Reported-$988,054.00(m)(m)(m)-455.86%(m)-$320.24K(m)$291.87K(m)(m)
2012-03-31Reported-$854,210.00(m)(m)(m)-212.73%(m)(m)(m)(m)(m)(m)
2011-12-31Reported-$337.24K*-$341.33K$4.08K*(m)(m)$0.00*-$65.04K*(m)$536.08K(m)(m)
2011-09-30Reported-$878.00K*-$882.96K$4.96K*(m)(m)$0.00*-$495.49K*(m)$117.82K(m)(m)
2011-06-30Reported-$1.03M*-$1.03M$4.81K(m)(m)$1.74K-$540.55K(m)$201.04K(m)(m)
2011-03-31Reported-$933,628.00(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-12-31Reported-$1.04M*-$1.05M$4.92K*(m)(m)$1.67K*-$549.72K*(m)(m)(m)(m)
2010-09-30Reported-$1.40M*-$1.41M$4.71K*(m)(m)$0.00*-$601.17K*(m)(m)(m)(m)
2010-06-30Reported-$1.16M*-$1.16M$4.67K(m)(m)$875.00-$362.08K(m)(m)(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-03-31Reported-$6.97M(m)(m)(m)(m)$3.70K-$7.00M(m)$1.91M(m)$0.00
2025-03-31Reported-$9M(m)(m)(m)(m)$0.00-$7.65M(m)$2.21M(m)$0.00
2024-03-31Reported-$12.28M(m)(m)(m)(m)$250.87K-$10.13M(m)$2.52M(m)$0.00
2023-03-31Reported-$11.66M(m)(m)(m)-2030.10%$943.11K-$10.51M(m)$2.75M(m)$0.00
2022-03-31Reported-$10.3M(m)(m)(m)-3500.48%$349.19K-$9.77M(m)$2.34M(m)$0.00
2021-03-31Reported-$7.85M(m)(m)(m)-1191.25%$59.88K-$6.76M(m)$2.07M(m)$0.00
2020-03-31Reported-$5.9M(m)(m)(m)-907.99%$151.66K-$5.20M(m)$927.00K(m)$0.00
2019-03-31Reported-$5.97M(m)(m)(m)-2599.16%$0.00-$4.29M(m)$896.00K(m)$0.00
2018-03-31Reported-$4.8M(m)(m)(m)-3204.98%$24.82K-$3.91M(m)$586.00K(m)$0.00
2017-03-31Reported-$6.07M(m)(m)(m)-1547.15%$16.43K-$3.51M(m)$673.00K(m)$0.00
2016-03-31Reported-$4.35M(m)(m)(m)-490.24%$9.31K-$4.33M(m)$782.00K(m)$0.00
2015-03-31Reported-$3.96M(m)(m)(m)-518.81%$0.00-$5.05M(m)$1.03M(m)$0.00
2014-03-31Reported-$3.03M(m)(m)(m)-186.90%$96.06K-$2.14M(m)$1.51M(m)$0.00
2013-03-31Reported-$3.56M(m)(m)(m)-289.83%$0.00-$2.10M(m)$1.44M(m)$0.00
2012-03-31Reported-$3.1M(m)(m)(m)-227.79%$1.74K-$1.84M(m)(m)(m)(m)
2011-03-31Reported-$4.54M(m)(m)(m)(m)$2.54K-$1.97M(m)(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32